Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
General Catalyst has completed the acquisition of Commure, a healthcare IT business in California, for $70 million. Commure provides AI and agentic automation for healthcare operations, including revenue cycle management and clinical workflow tools used by health systems and physician practices. Deployed across more than 500 healthcare organizations and 3,000+ care sites, its ambient AI supports autonomous coding and clinical intelligence for tens of millions of appointments annually. The platform acquisition is backed by private equity acquisition dynamics with participation from Sequoia Capital and Morgan Stanley, valuing Commure at $7 billion post-money. As a healthcare deals CA platform acquisition, the goal is to reduce administrative burden in U.S. healthcare by automating coding, claims, denials, and appeals with minimal human intervention.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026